|
|
Duragesic Patch - Newsfeeds
-
-
Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today announced that two private insurance payers have elected to cover posterior tibial nerve ...
-
-
"Our hypothesis is that the antidepressant medication is blocking the inflammatory proteins that inhibit cellular growth and that's why you get the cellular growth in certain parts of the brain ," said Robinson, who also holds the Paul W. Penningroth Chair ...
-
-
Watson Pharmaceuticals, Inc. announced Tuesday that one lot of 100 mcg/hr Fentanyl Transdermal System patches sold in the U.S. is being voluntarily recalled from wholesalers and pharmacies. The recalled patches are from Lot Number 145287A, have expiration ...
-
-
Watson Pharmaceuticals, Inc. announced Tuesday that one lot of 100 mcg/hr Fentanyl Transdermal System patches sold in the U.S. is being voluntarily recalled from wholesalers and pharmacies. The recalled patches are from Lot Number 145287A, have expiration ...
-
-
ALZA Corp, et al. Janice DiCosolo died on February 15, 2004, while using a Duragesic fentanyl patch prescribed by her doctor to reduce pain from the neurological condition reflex sympathetic dystrophy. Duragesic patches contain a gel form of the pain ...
-
-
ALZA Corp, et al . Janice DiCosolo died on Feb. 15, 2004 , while using a Duragesic® fentanyl patch prescribed by her doctor to reduce pain from the neurological condition reflex sympathetic dystrophy. Duragesic patches contain a gel form of the pain ...
-
-
(RTTNews) - The First District of the Illinois Court of Appeals has received final briefing in the appeal of a $16.56 million judgment entered more than two years ago against Johnson & Johnson (JNJ: News ) subsidiaries Janssen Pharmaceutica Inc. and ALZA ...
-
-
Its most prominent brands include Remicade, Procrit (or Eprex outside of the US), Levaquin, Risperdal Consta, Concerta, Aciphex/Pariet, Duragesic (or Durogesic outside of the US), Velcade, Prezista and Invega. The Consumer segment includes a broad range of ...
-
-
Drugs that require the new educational guidelines include Johnson & Johnson's Duragesic, Pfizer Inc unit King Pharma's Avinza and Embeda, Actavis' Kadian and Endo Pharmaceuticals' Opana ER. The list also includes some generic opioid drugs made by Mylan ...
-
-
April 19, 2011 -- Ignoring its expert advisory panel's strong "no" vote, the FDA today launched an education program to cut abuse of long-lasting opioid pain drugs. The action calls for companies that make long-lasting or extended-release opioid pain drugs ...
-
-
Drugs that now require the new educational guidelines include Johnson & Johnson's Duragesic, Pfizer Inc unit King Pharma's Avinza and Embeda, Actavis' Kadian and Endo Pharmaceuticals' Opana ER. The list also includes generic opioid drugs made by Mylan ...
-
-
Advertisements on this site are placed and controlled by outside advertising networks. ConsumerAffairs.com does not evaluate or endorse the products and services advertised. See the FAQ for more information. Company Response Welcome If complaints about ...
-
-
Sign up for KTLA 5 Breaking News Email Alerts Certain drugs the companies sell are being abused— a lot, says the FDA in a consumer update : “FDA experts say extended-release and long-acting opioids—including OxyContin, Avinza, Dolophine, Duragesic ...
-
-
“FDA experts say extended-release and long-acting opioids—including OxyContin, Avinza, Dolophine, Duragesic and eight other brand names—are extensively misprescribed, misused, and abused, leading to overdoses, addiction and even deaths across the United States.
-
-
LifeSpan medicine is excited to announce the launch of the LifeSpan Healthy Kids Program. There is nothing more important to a lifespan of health than a good start. Who would not want to have a better, healthier childhood for their kids than they ...
-
-
DURAGESIC/Fentanyl Transdermal, a treatment for chronic pain; VELCADE for the treatment of multiple myeloma; PREZISTA for treating HIV/AIDS patients; and INVEGA, a atypical antipsychotic. The Medical Devices and Diagnostics segment primarily offers ...
-
-
New products like Stelara, Simponi and Invega Sustenna also contributed to growth. Meanwhile, products like Aciphex, Duragesic/Fentanyl Transdermal, Procrit/Eprex, and Topamax continued to record a decline in sales. Topamax continued to be impacted by generic competition.
-
-
Convergence Pharmaceuticals Limited ("Convergence"), the company focused on the development of novel and high value analgesic medicines, today announced that the first-time-in-man Phase I study of the novel, first in class calcium channel blocker ...
-
-
Pfizer Inc. (PFE) , Johnson & Johnson (JNJ) and Endo Pharmaceuticals Holdings Inc. (ENDP) will have to train doctors before they can give patients extended-release painkillers under a U.S. plan aimed at reducing prescription drug abuse. Sixteen companies ...
-
-
WASHINGTON, April 19 (Reuters) - The U.S. health regulator ordered painkiller makers to provide educational materials to help train physicians about the correct use of the drugs, as part of the Obama administration's plan to tackle prescription drug abuse ...
Content provided by MSN. LegalView is not responsible for the accuracy of the information provided above.
Pages:
1
2
3
4
5
6
...
Next
|
Duragesic Patch Information
|
